THEMISMED.BOTHEMISMED.BOBSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank95
5Y CAGR+25.9%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+25.9%/yr
Long-term compound
Percentile
P95
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 227.25% |
| Q3 2025 | 55.19% |
| Q2 2025 | -51.93% |
| Q1 2025 | -238.86% |
| Q4 2024 | -59.20% |
| Q3 2024 | -45.17% |
| Q2 2024 | 328.98% |
| Q1 2024 | 25.64% |
| Q4 2023 | -68.95% |
| Q3 2023 | -36.04% |
| Q2 2023 | 92.38% |
| Q1 2023 | -34.09% |
| Q4 2022 | -21.10% |
| Q3 2022 | 39.67% |
| Q2 2022 | 48.90% |
| Q1 2022 | -19.47% |
| Q4 2021 | -29.21% |
| Q3 2021 | -44.69% |
| Q2 2021 | 286.26% |
| Q1 2021 | -25.02% |
| Q4 2020 | 71.88% |
| Q3 2020 | -25.34% |
| Q2 2020 | -9.90% |
| Q1 2020 | 56.78% |
| Q4 2019 | 115.55% |
| Q3 2019 | -38.10% |
| Q2 2019 | 165.98% |
| Q1 2019 | -1997.74% |
| Q4 2018 | -151.41% |
| Q3 2018 | -64.87% |
| Q2 2018 | -71.26% |
| Q1 2018 | 101.43% |
| Q4 2017 | -51.19% |
| Q3 2017 | 133.41% |
| Q2 2017 | -30.08% |
| Q1 2017 | -13.28% |
| Q4 2016 | -48.45% |
| Q3 2016 | 6.90% |
| Q2 2016 | 57.17% |
| Q1 2016 | -14.17% |